Jenburkt Pharmaceuticals Ltd

NSE: JENBURPH · BSE: 524731 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹948.40
Market cap: ₹418.6 Cr
Revenue (annual): ₹168.7 Cr
Net profit (annual): ₹34.74 Cr
P/E (TTM): 12.8×Sector 50.4×
Promoter holding: 46.62%-0.02% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 2 Financial Results 2 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Sep 2026 16:23 IST BSE

Management Change

Jenburkt Pharmaceuticals Management Change

Mr. Vinay Bhatt, Senior Vice President- International Business, has resigned from Jenburkt Pharmaceuticals Limited effective September 18, 2026, due to personal reasons.

Read the filing ↗

4 Sep 2026 12:40 IST BSE

Management Change

Jenburkt Pharmaceuticals Management Change

Jenburkt Pharmaceuticals elevated Shri Prem Ashish Bhuta to Associate Vice President – Strategic Initiatives. He is now classified as Senior Management Personnel effective September 4, 2026.

Read the filing ↗